On July 30 the White House released an updated version of its National HIV/AIDS Strategy, outlining the administration's plans through the year 2020. In keeping with recent research, the revised strategy includes an increased emphasis on early antiretroviral treatment and pre-exposure prophylaxis (PrEP), as well as focusing on underserved and heavily affected population groups including young gay men, transgender women, and African-Americans.
"We talk a lot about the success of treatment as prevention in Vancouver, but we always need to make sure people understand that this requires an integration of various approaches," Evan Wood of the University of British Columbia said last week in a plenary presentation at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.
HIVandHepatitis.com coverage of the International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), July 19-22, in Vancouver, Canada.
Conference highlights include HIV treatment as prevention, pre-exposure prophylaxis (PrEP), new antiretroviral therapies, HIV cure research, hepatitis C and HIV/HCV coinfection, and global scale-up of prevention and treatment.
A program at San Francisco General Hospital (SFGH) that offers antiretroviral therapy (ART) on the same day as HIV diagnosis led to a high rate of treatment uptake and more rapid viral load suppression than standard practices, according to late-breaking study findings presented at the 8th International AIDS Society Conference this week in Vancouver. Newly diagnosed people with HIV and clinic providers both expressed enthusiasm about the RAPID program, which is now being implemented more widely as part of the city's Getting to Zero initiative.